bendamustine,ibrutinib,tisagenlecleucel
teva,abbvie,janssen,novartis
['bendamustine', ' ibru', 'tarmac', 'tisa-cel', 'lymsm']
#tarmac: ibr + tisa-cel in mcl - bendamustine-exposed patients did poorly: are their t-cells irrevocably damaged by bendamustine?
- given 45% of pts ibrutinib refractory, how was disease controlled during cell manufacture? 4 pts had bridging therapy w gemox x1-2 #ash22 #lymsm
haematology registrar | fellow @PORTAL_research @harvardmed |
evidence-based medicine | health policy | lymphoma | myeloma |
Fulbright scholar | muso | writer